alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. 1996

N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
Department of Medicine, Howard Hughes Medical Institute, University of California, San Francisco 94143, USA.

Two families of protein tyrosine kinases (PTKs), the Src and Syk/ZAP-70 families, are required for T cell development. Lck is the major Src family member required for thymopoiesis, since there is a severe deficit of CD4+CD8+ thymocytes and mature T cells in its absence. However, some peripheral T cells are evident in these mice, suggesting that additional PTKs may contribute to T cell development. Here we show that the combined disruption of Lck and Fyn (lck(-/-)fyn(-/-)) completely arrests alpha beta T cell development at the CD4-CD8- stage. The development of V gamma 3+ dendritic epidermal T cells is also severely impaired, but natural killer cell development and cytolytic activity is unaffected in lck(-/-)fyn(-/-) mice. These findings reveal the potential for redundant functions mediated by Src family PTKs while emphasizing crucial roles for Lck and Fyn in T cell development.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets
D016693 Receptors, Antigen, T-Cell, alpha-beta T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility (MHC) molecules. Antigen Receptors, T-Cell, alpha-beta,T-Cell Receptors alpha-Chain,T-Cell Receptors beta-Chain,T-Cell Receptors, alpha-beta,TcR alpha-beta,Antigen T Cell Receptor, alpha Chain,Antigen T Cell Receptor, beta Chain,Receptors, Antigen, T Cell, alpha beta,T Cell Receptors, alpha beta,T-Cell Receptor alpha-Chain,T-Cell Receptor beta-Chain,T-Cell Receptor, alpha-beta,T Cell Receptor alpha Chain,T Cell Receptor beta Chain,T Cell Receptor, alpha beta,T Cell Receptors alpha Chain,T Cell Receptors beta Chain,TcR alpha beta,alpha-Chain, T-Cell Receptor,alpha-Chain, T-Cell Receptors,alpha-beta T-Cell Receptor,alpha-beta T-Cell Receptors,alpha-beta, TcR,beta-Chain, T-Cell Receptor,beta-Chain, T-Cell Receptors
D051076 Proto-Oncogene Proteins c-fyn Src-family kinases that associate with T-CELL ANTIGEN RECEPTOR and phosphorylate a wide variety of intracellular signaling molecules. Proto-Oncogene Protein p60(fyn),c-fyn Protein,fyn Proto-Oncogene Proteins,Fyn Tyrosine Kinase,Protein-Tyrosine Kinase p59(fyn),Proto-Oncogene Protein c-fyn,Proto-Oncogene Protein c-syn,Proto-Oncogene Protein p59(fyn),Proto-Oncogene Protein p72(fyn),c-fyn Proto-Oncogene Proteins,p59 c-fyn Protein,p59(fyn) Protein,p60 c-fyn Protein,p60(fyn) Protein,p72 c-fyn Protein,p72(fyn) Protein,Proteins c-fyn, Proto-Oncogene,Proto Oncogene Protein c fyn,Proto Oncogene Protein c syn,Proto Oncogene Proteins c fyn,Proto-Oncogene Proteins, c-fyn,Proto-Oncogene Proteins, fyn,Tyrosine Kinase, Fyn,c fyn Proto Oncogene Proteins,c-fyn Protein, p59,c-fyn Protein, p60,c-fyn, Proto-Oncogene Protein,c-fyn, Proto-Oncogene Proteins,c-syn, Proto-Oncogene Protein,fyn Proto Oncogene Proteins,p59 c fyn Protein,p60 c fyn Protein,p72 c fyn Protein

Related Publications

N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
May 1994, The Journal of cell biology,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
February 1997, European journal of immunology,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
April 1999, Molecular biology of the cell,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
March 1997, The Journal of biological chemistry,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
October 2004, Oncogene,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
March 2012, Yi chuan = Hereditas,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
July 2003, International immunopharmacology,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
January 2011, Molecular neurodegeneration,
N S van Oers, and B Lowin-Kropf, and D Finlay, and K Connolly, and A Weiss
June 1992, Science (New York, N.Y.),
Copied contents to your clipboard!